Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 3-o-methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway.

× No keyword cloud information.

7 in total

1. In vivo effects of new inhibitors of catechol-O-methyl transferase.

Authors: E Rivas; M L de Ceballos; O Nieto; J A Fontenla
Journal: Br J Pharmacol Date: 1999-04 Impact factor: 8.739

2. Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone.

Authors: T Keränen; A Gordin; M Karlsson; K Korpela; P J Pentikäinen; H Rita; E Schultz; L Seppälä; T Wikberg
Journal: Eur J Clin Pharmacol Date: 1994 Impact factor: 2.953

3. Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.

Authors: A Fredriksson; T Archer
Journal: J Neural Transm Gen Sect Date: 1995

4. The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.

Authors: N Himori; K Mishima
Journal: Experientia Date: 1994-10-15

5. Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease.

Authors: V V Myllylä; K A Sotaniemi; A Illi; K Suominen; T Keränen
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953

6. DL-threo-DOPS as a precursor of noradrenaline.

Authors: A Reches; V Jackson-Lewis; S Fahn
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1985-11 Impact factor: 3.000

Review 7. Tolcapone-related liver dysfunction: implications for use in Parkinson's disease therapy.

Authors: Nuno Borges
Journal: Drug Saf Date: 2003 Impact factor: 5.606

7 in total